Log in to save to my catalogue

Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Rea...

Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Rea...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5984916

Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA

About this item

Full title

Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA

Publisher

Cheshire: Springer Healthcare

Journal title

Diabetes therapy, 2018-06, Vol.9 (3), p.1347-1358

Language

English

Formats

Publication information

Publisher

Cheshire: Springer Healthcare

More information

Scope and Contents

Contents

Introduction
Basal insulin (BI) plays an important role in treating type 2 diabetes (T2D), especially when oral antidiabetic (OAD) medications are insufficient for glycemic control. We conducted a retrospective, observational study using electronic medical records (EMR) data from the IBM
®
Explorys database to evaluate the probability of a...

Alternative Titles

Full title

Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5984916

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5984916

Other Identifiers

ISSN

1869-6953

E-ISSN

1869-6961

DOI

10.1007/s13300-018-0413-5

How to access this item